Acquavella, Chiarelli, Shuster, Berkower & Co., LLP

Consent of Independent Registered Public Accounting Firm

We consent to the use in this Registration Statement on Form S-1, Pre-Effective Amendment No. 3, for Tibet Pharmaceuticals, Inc. of our audit report dated July 19, 2010, relating to the consolidated financial statements of Tibet Pharmaceuticals, Inc. (formerly named Shangri-La Tibetan Pharmaceuticals, Inc., the “Company”) as of December 31, 2009 and 2008 and for the years then ended, and of our review report dated September 21, 2010, relating to the consolidated financial statements of the Company as of June 30, 2010 and December 31, 2009, and for the periods ended June 30, 2010 and 2009, and to the reference to our firm under the heading “Expert” in the prospectus.

/s/    Acquavella, Chiarelli, Shuster, Berkower & Co., LLP

New York, NY

September 21, 2010